Pharmameditech Scientific Equipment Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-01-2025
- Paid Up Capital ₹ 0.50 M
as on 08-01-2025
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.00 M
as on 08-01-2025
- Revenue -3.08%
(FY 2020)
- Profit -49.71%
(FY 2020)
- Ebitda -22.88%
(FY 2020)
- Net Worth 18.48%
(FY 2020)
- Total Assets -0.99%
(FY 2020)
About Pharmameditech Scientific Equipment
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Shivan Babu and Tomzacharia serve as directors at the Company.
- CIN/LLPIN
U33110KA2015PTC081020
- Company No.
081020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharmameditech Scientific Equipment Private Limited offer?
Pharmameditech Scientific Equipment Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Chamber, Cooling Chamber, Humidity Chambers, Deep Freezer, SS Deep Freezer, Lab Incubator, Bod Incubator, Sterilizer, Autoclaves, Sterilizers & Incubators.
Who are the key members and board of directors at Pharmameditech Scientific Equipment?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivan Babu  | Director | 19-Jun-2015 | Current |
| Tomzacharia | Director | 19-Jun-2015 | Current |
Financial Performance of Pharmameditech Scientific Equipment.
Pharmameditech Scientific Equipment Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.08% decrease. The company also saw a substantial fall in profitability, with a 49.71% decrease in profit. The company's net worth Soared by an impressive increase of 18.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmameditech Scientific Equipment?
In 2018, Pharmameditech Scientific Equipment had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Mar 2018 | ₹3.00 M | Open |
How Many Employees Work at Pharmameditech Scientific Equipment?
Pharmameditech Scientific Equipment has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmameditech Scientific Equipment, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmameditech Scientific Equipment's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
